Iron dextran

Suppliers

Names

[ CAS No. ]:
9004-66-4

[ Name ]:
Iron dextran

[Synonym ]:
MFCD00081553
Ferric hydroxide dextran complex

Chemical & Physical Properties

[ Molecular Formula ]:
H2O4S.Fe

[ Molecular Weight ]:
1347.364

[ Exact Mass ]:
1346.576050

[ Appearance of Characters ]:
solution

Safety Information

[ Symbol ]:

GHS07, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H317-H350

[ Precautionary Statements ]:
P201-P280-P308 + P313

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R40;R42/43

[ Safety Phrases ]:
S23;S26;S45;S36/S37/S39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
-

[ RTECS ]:
NI2200000

Articles

Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status

Exp. Hematol. 41(6) , 539-46, (2013)

Numerous studies have shown the antiproliferative effect of iron chelating agents (ICAs), which have been used traditionally in patients with secondary iron overload (SIO). Because the in vivo model f...

[Importance of the different i.v. iron generations for everyday medical practice].

MMW Fortschr. Med. 155 Suppl 1 , 18-24, (2013)

Iron deficiency and anaemia occur in particular in women or as comorbid conditions to a varietyof chronic diseases. Besides oral preparations, parenteral iron therapies are also available for the trea...

Use of intravenous iron supplementation in chronic kidney disease: an update.

Iran. J. Kidney Dis. 7(1) , 9-22, (2013)

Iron deficiency is an important clinical concern in chronic kidney disease (CKD), giving rise to iron-deficiency anemia and impaired cellular function. Oral supplementation, in particular with ferrous...


More Articles

Related Compounds

  • iron(iii) citrate hydrate, 98
  • IRON SILICIDE
  • iron(iii) titanium oxide
  • iron 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)
  • Iron, 2-ethylhexanoate naphthenate complexes
  • Iron oxide brown
  • 4-bromo-6-hydroxy-1,5-naphthyridine-3-carboxylic Acid
  • N-(2-methoxypyrimidin-5-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide
  • N1-(2-methoxyphenyl)-N2-(2-(4-(thiophen-2-yl)piperidin-1-yl)ethyl)oxalamide
  • 1-(3-methoxy-7-nitro-10H-phenothiazin-10-yl)ethanone
  • N1-(2,5-difluorophenyl)-N2-(2-(4-(thiophen-2-yl)piperidin-1-yl)ethyl)oxalamide
  • 1-[2-(4-Methoxyphenyl)ethyl]-3-{2-[4-(thiophen-2-yl)piperidin-1-yl]ethyl}urea
  • Methyl 4-((4-(thiophen-3-yl)piperidin-1-yl)sulfonyl)benzoate
  • 2-(4-{[4-(Thiophen-3-yl)piperidin-1-yl]sulfonyl}phenyl)-1lambda6,2-thiazinane-1,1-dione
  • N-(2-hydroxy-2-methyl-3-(methylthio)propyl)-3,3-dimethylbutanamide
  • N-(2-hydroxy-2-methyl-3-(methylthio)propyl)-1-naphthamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.